Logo image of CTRE

CARETRUST REIT INC (CTRE) Stock Fundamental Analysis

NYSE:CTRE - New York Stock Exchange, Inc. - US14174T1079 - REIT

27.19  +0.46 (+1.72%)

After market: 26.57 -0.62 (-2.28%)

Fundamental Rating

6

Taking everything into account, CTRE scores 6 out of 10 in our fundamental rating. CTRE was compared to 129 industry peers in the Diversified REITs industry. CTRE has an excellent profitability rating, but there are some minor concerns on its financial health. CTRE is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, CTRE could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CTRE was profitable.
In the past year CTRE had a positive cash flow from operations.
Of the past 5 years CTRE 4 years were profitable.
In the past 5 years CTRE always reported a positive cash flow from operatings.
CTRE Yearly Net Income VS EBIT VS OCF VS FCFCTRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M

1.2 Ratios

The Return On Assets of CTRE (3.38%) is better than 82.54% of its industry peers.
CTRE's Return On Equity of 4.08% is fine compared to the rest of the industry. CTRE outperforms 65.87% of its industry peers.
CTRE has a Return On Invested Capital of 4.92%. This is amongst the best in the industry. CTRE outperforms 90.48% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CTRE is above the industry average of 3.11%.
Industry RankSector Rank
ROA 3.38%
ROE 4.08%
ROIC 4.92%
ROA(3y)2.14%
ROA(5y)2.96%
ROE(3y)3.55%
ROE(5y)4.89%
ROIC(3y)5.48%
ROIC(5y)5.38%
CTRE Yearly ROA, ROE, ROICCTRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 4 6 8

1.3 Margins

With an excellent Profit Margin value of 36.73%, CTRE belongs to the best of the industry, outperforming 88.10% of the companies in the same industry.
CTRE's Profit Margin has declined in the last couple of years.
CTRE's Operating Margin of 65.34% is amongst the best of the industry. CTRE outperforms 99.21% of its industry peers.
In the last couple of years the Operating Margin of CTRE has grown nicely.
With an excellent Gross Margin value of 98.16%, CTRE belongs to the best of the industry, outperforming 98.41% of the companies in the same industry.
Industry RankSector Rank
OM 65.34%
PM (TTM) 36.73%
GM 98.16%
OM growth 3Y1.9%
OM growth 5Y3.08%
PM growth 3Y-18.48%
PM growth 5Y-7.78%
GM growth 3YN/A
GM growth 5YN/A
CTRE Yearly Profit, Operating, Gross MarginsCTRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CTRE is destroying value.
The number of shares outstanding for CTRE has been increased compared to 1 year ago.
Compared to 5 years ago, CTRE has more shares outstanding
CTRE has a better debt/assets ratio than last year.
CTRE Yearly Shares OutstandingCTRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CTRE Yearly Total Debt VS Total AssetsCTRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

CTRE has an Altman-Z score of 6.28. This indicates that CTRE is financially healthy and has little risk of bankruptcy at the moment.
CTRE has a Altman-Z score of 6.28. This is amongst the best in the industry. CTRE outperforms 99.21% of its industry peers.
CTRE has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CTRE (0.16) is better than 97.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 6.28
ROIC/WACC0.56
WACC8.74%
CTRE Yearly LT Debt VS Equity VS FCFCTRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B

2.3 Liquidity

A Current Ratio of 4.14 indicates that CTRE has no problem at all paying its short term obligations.
CTRE's Current ratio of 4.14 is amongst the best of the industry. CTRE outperforms 91.27% of its industry peers.
A Quick Ratio of 4.14 indicates that CTRE has no problem at all paying its short term obligations.
The Quick ratio of CTRE (4.14) is better than 91.27% of its industry peers.
Industry RankSector Rank
Current Ratio 4.14
Quick Ratio 4.14
CTRE Yearly Current Assets VS Current LiabilitesCTRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

8

3. Growth

3.1 Past

CTRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.61%, which is quite impressive.
Measured over the past years, CTRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.79% on average per year.
Looking at the last year, CTRE shows a very strong growth in Revenue. The Revenue has grown by 28.22%.
Measured over the past years, CTRE shows a small growth in Revenue. The Revenue has been growing by 6.78% on average per year.
EPS 1Y (TTM)75.61%
EPS 3Y-17.34%
EPS 5Y-7.79%
EPS Q2Q%162.5%
Revenue 1Y (TTM)28.22%
Revenue growth 3Y6.89%
Revenue growth 5Y6.78%
Sales Q2Q%38.48%

3.2 Future

The Earnings Per Share is expected to grow by 45.40% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 23.98% on average over the next years. This is a very strong growth
EPS Next Y77.44%
EPS Next 2Y69.27%
EPS Next 3Y45.4%
EPS Next 5YN/A
Revenue Next Year19.48%
Revenue Next 2Y25.2%
Revenue Next 3Y23.98%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CTRE Yearly Revenue VS EstimatesCTRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
CTRE Yearly EPS VS EstimatesCTRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 37.76, CTRE can be considered very expensive at the moment.
CTRE's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of CTRE to the average of the S&P500 Index (28.29), we can say CTRE is valued slightly more expensively.
Based on the Price/Forward Earnings ratio of 19.77, the valuation of CTRE can be described as rather expensive.
Based on the Price/Forward Earnings ratio, CTRE is valued cheaper than 92.06% of the companies in the same industry.
CTRE is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 37.76
Fwd PE 19.77
CTRE Price Earnings VS Forward Price EarningsCTRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTRE indicates a rather expensive valuation: CTRE more expensive than 88.89% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.15
CTRE Per share dataCTRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CTRE has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CTRE's earnings are expected to grow with 45.40% in the coming years.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y69.27%
EPS Next 3Y45.4%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.26%, CTRE is a good candidate for dividend investing.
CTRE's Dividend Yield is comparable with the industry average which is at 18.51.
Compared to an average S&P500 Dividend Yield of 2.28, CTRE pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.26%

5.2 History

The dividend of CTRE has a limited annual growth rate of 5.26%.
CTRE has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of CTRE decreased in the last 3 years.
Dividend Growth(5Y)5.26%
Div Incr Years2
Div Non Decr Years2
CTRE Yearly Dividends per shareCTRE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

156.68% of the earnings are spent on dividend by CTRE. This is not a sustainable payout ratio.
The dividend of CTRE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP156.68%
EPS Next 2Y69.27%
EPS Next 3Y45.4%
CTRE Yearly Income VS Free CF VS DividendCTRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M
CTRE Dividend Payout.CTRE Dividend Payout, showing the Payout Ratio.CTRE Dividend Payout.PayoutRetained Earnings

CARETRUST REIT INC

NYSE:CTRE (1/21/2025, 8:04:00 PM)

After market: 26.57 -0.62 (-2.28%)

27.19

+0.46 (+1.72%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-29 2024-10-29/amc
Earnings (Next)02-06 2025-02-06/amc
Inst Owners96.38%
Inst Owner Change0.04%
Ins Owners0.47%
Ins Owner Change-2.25%
Market Cap5.08B
Analysts82.5
Price Target34.07 (25.3%)
Short Float %4.4%
Short Ratio3.1
Dividend
Industry RankSector Rank
Dividend Yield 4.26%
Yearly Dividend1.01
Dividend Growth(5Y)5.26%
DP156.68%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-51.46%
Min EPS beat(2)-73.43%
Max EPS beat(2)-29.49%
EPS beat(4)0
Avg EPS beat(4)-31.51%
Min EPS beat(4)-73.43%
Max EPS beat(4)-9.38%
EPS beat(8)0
Avg EPS beat(8)-45.82%
EPS beat(12)1
Avg EPS beat(12)-40.75%
EPS beat(16)3
Avg EPS beat(16)-30.02%
Revenue beat(2)2
Avg Revenue beat(2)16.99%
Min Revenue beat(2)0.19%
Max Revenue beat(2)33.8%
Revenue beat(4)2
Avg Revenue beat(4)7.99%
Min Revenue beat(4)-1.16%
Max Revenue beat(4)33.8%
Revenue beat(8)5
Avg Revenue beat(8)5.09%
Revenue beat(12)7
Avg Revenue beat(12)3.05%
Revenue beat(16)8
Avg Revenue beat(16)2.01%
PT rev (1m)-0.79%
PT rev (3m)12.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.42%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)4.45%
Revenue NY rev (3m)10.34%
Valuation
Industry RankSector Rank
PE 37.76
Fwd PE 19.77
P/S 18.9
P/FCF N/A
P/OCF 24.02
P/B 2.1
P/tB 2.1
EV/EBITDA 22.15
EPS(TTM)0.72
EY2.65%
EPS(NY)1.38
Fwd EY5.06%
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)1.13
OCFY4.16%
SpS1.44
BVpS12.95
TBVpS12.95
PEG (NY)0.49
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.38%
ROE 4.08%
ROCE 6.23%
ROIC 4.92%
ROICexc 5.68%
ROICexgc 5.68%
OM 65.34%
PM (TTM) 36.73%
GM 98.16%
FCFM N/A
ROA(3y)2.14%
ROA(5y)2.96%
ROE(3y)3.55%
ROE(5y)4.89%
ROIC(3y)5.48%
ROIC(5y)5.38%
ROICexc(3y)5.83%
ROICexc(5y)5.61%
ROICexgc(3y)5.83%
ROICexgc(5y)5.61%
ROCE(3y)6.94%
ROCE(5y)6.8%
ROICexcg growth 3Y2.68%
ROICexcg growth 5Y2.78%
ROICexc growth 3Y2.68%
ROICexc growth 5Y2.78%
OM growth 3Y1.9%
OM growth 5Y3.08%
PM growth 3Y-18.48%
PM growth 5Y-7.78%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 1.72
Cap/Depr 564.92%
Cap/Sales 114.69%
Interest Coverage 5.59
Cash Conversion 91.87%
Profit Quality N/A
Current Ratio 4.14
Quick Ratio 4.14
Altman-Z 6.28
F-Score6
WACC8.74%
ROIC/WACC0.56
Cap/Depr(3y)298.03%
Cap/Depr(5y)342.19%
Cap/Sales(3y)76.85%
Cap/Sales(5y)97.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.61%
EPS 3Y-17.34%
EPS 5Y-7.79%
EPS Q2Q%162.5%
EPS Next Y77.44%
EPS Next 2Y69.27%
EPS Next 3Y45.4%
EPS Next 5YN/A
Revenue 1Y (TTM)28.22%
Revenue growth 3Y6.89%
Revenue growth 5Y6.78%
Sales Q2Q%38.48%
Revenue Next Year19.48%
Revenue Next 2Y25.2%
Revenue Next 3Y23.98%
Revenue Next 5YN/A
EBIT growth 1Y34.35%
EBIT growth 3Y8.92%
EBIT growth 5Y10.06%
EBIT Next Year91.55%
EBIT Next 3Y47.28%
EBIT Next 5Y29.83%
FCF growth 1Y-189.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.9%
OCF growth 3Y2.03%
OCF growth 5Y9.26%